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Chitosan is a natural macromolecular polysaccharide, derived from chitin extracted from 
the exoskeleton of some marine invertebrates. This study was designed to evaluate the 
expression of P-selectin, thromboxane A2 (TXA2), transforming growth factor-β1 (TGF-
β1) and platelet derived growth factor-AB (PDGF-AB) using enzyme-linked 
immunosorbent assays (ELISAs). The chitosan derivatives utilized were 7% N,O-
carboxymethylchitosan (NO-CMC) (with 0.45 mL collagen), 8% NO-CMC, oligo -
chitosan (O-C) and oligo -chitosan 53 (O-C 53). We found that O-C showed a 
significantly superior effect compared to NO-CMC in achieving hemostasis. Post-hoc 
multiple comparisons using Scheffe test indicated that p-values between the mean 
differences of all the assayed chitosan derivatives were not significant. However, our 
analyses successfully identified distinctions between the O-C and NO-CMC test groups 
and blood alone. These results may expand the understanding of the ability of chitosan 
derivatives to promote inflammatory responses and angiogenesis depending on their 
physical and chemical structures. 
KEYWORDS: Chitosan, P-selectin, TXA2, TGF-β1, PDGF-AB 
INTRODUCTION 
In many hospital settings, maintaining a good hemostatic balance in bleeding patients 
remains a major challenge.
1
 Successful approaches in hemostasis research may contribute 
to a significant reduction in hemorrhage related fatality. Among the novel hemostatic 
agents approved by the U.S. Food and Drug Administration (FDA), chitosan-based 
agents have shown great promise in preventing major hemorrhaging in the pre-hospital 
setting and in animal models of major blood loss.
2 
Chitosan is derived from chitin, which 
can be extracted from the exoskeleton of some marine invertebrates. Chitosan is well 
Abstract 
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known for its potential as a non-toxic, biocompatible and biodegradable product.
3,4
 
Chitosan has the ability to expedite the wound healing process, arresting bleeding by 
facilitating platelet recruitments and promoting coagulation by forming a pseudo-clot. 
The chitosan structure can be chemically modified, and has been widely employed both 
as a biomaterial scaffold, for the controlled release of pharmaceuticals and as a 
component of successful wound dressing.
5,6
 The compatability of chitosan biomaterials is 
a feature of sample preparation, viscosity, molecular weight, degree of deacetylation, 
incubation period and temperature. Although the study of chitosan in hemostasis has been 
the subject of intense research, to the best of our knowledge, few studies have been 
conducted on the effect of chitosan adhesion on platelet mediators. Therefore, this study 
measured the levels of P-selectin, thromboxane A2 (TXA2), transforming growth factor-
β1 (TGF-β1) and platelet derived growth factor-AB (PDGF-AB). These mediators ease 
the activation of platelets to form the primary hemostatic plug and are involved in the 
rolling of platelets and neutrophils on activated endothelial cells promoting faster wound 
recovery.
7,8
 We predict that varying formulations of chitosan- based hemostatic agents 
may have different potential roles in expediting hemostasis. In our research we used N,O-
carboxymethylchitosan (NO-CMC) and oligo-chitosan (O-C) produced by the Standard 
and Industrial Research Institute of Malaysia (SIRIM Berhad) with degrees and 
acetylation between 75-95%. Our results showed that P-selectin, TXA2, TGF-β1 and 
PDGF-AB respond differently to the presence of chitosan derivatives with different 
molecular weights and degrees of deacetylation, which may facilitate the innovation of 
chitosan biomaterials to expedite hemostasis. 
 
MATERIALS AND METHODS 
Subjects 
We recruited 80 healthy male and female donors aged 18 to 40 years and obtained written 
informed consent. Prior to commencing the study, ethical clearance was obtained from 
the Human Ethics Committee of Universiti Sains Malaysia (USM). None of the female 
donors were taking oral contraceptives when the blood samples were withdrawn. None of 
the healthy donors had been diagnosed with chronic diseases. Twelve milliliters of whole 
blood was withdrawn from the antecubital vein into three vials of 
ethylenediaminetetraacetic acid (EDTA) tubes for all the studies except for P-selectin. To 
evaluate P-selectin expression, three- way stop-cocks were used to collect blood under 
minimal tourniquet pressure, and the first 1mL of blood withdrawn was discarded. The 
remainder of each blood sample was aliquoted into 3 tubes containing 3.2% sodium 
citrate. Subject selection was contingent on a hematocrit level between 38% and 45% and 
a normal platelet count between 150 x 10
3
/µL and 350 x 10
3
/µL. 
Materials 
Chitosan sponges with variable chitosan formulations (7% NO-CMC with 0.45 mL 
collagen, 8% NO-CMC, O-C and one powdered type of chitosan termed O-C 53) were 
used. Lyostypt
® 
was used as the positive control. 
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Methods 
Blood samples were centrifuged at 1000 x g for 10 minutes. Supernatants were harvested 
and then centrifuged again at 10000 x g for 10 minutes. Chitosan samples, each weighing 
10 mg, were dissolved in 50 µL of phosphate-buffered saline (PBS) (pH 7.4) and 
subjected to incubation at 37 ºC for 60 minutes. Five hundred microliters of platelet-rich 
plasma (PRP) was then mixed with each prepared chitosan sample for 30 minutes.
9-11
 
Measurement of TXA2, P-Selectin, TGF-β1 and PDGF-AB 
Levels of the above platelet mediators in serum upon adhesion to chitosans were 
measured using Quantikine colorimetric sandwich ELISA kits [TGF-β1 (Cat. No. 
DB100B), PDGF-AB (Cat. No. DHD00C) (R&D Systems, Minneapolis, MN, USA)];   
P-selectin (Cat. No. CSB-E04708h), TXA2 (Cat. No. CSB-E09619h) (Cusabio Biotech 
Co., LTD)] according to the manufacturer’s instructions. TGF-β1 was activated in the 
samples as directed in the assay protocol. Reactions were stopped, and absorbance was 
determined at 450 nm utilizing an ELISA reader (Tecan Infinite 200 PRO NanoQuant, 
Switzerland). A standard curve was generated, and the concentration of each sample was 
determined in ng/mL and pg/mL. Protein expression was calculated based on the volume 
of supernatant obtained after clot retraction. The standard curve was generated by 
plotting the absorbance for each standard on the y-axis against its concentration on the x-
axis, and drawing a best-fit curve through all the data points.
12
 No significant cross-
reactivity or interference was observed among all the measurement levels. 
 
Statistical analysis 
All the data were presented as means with standard deviations. Statistical significance 
was evaluated using one-way analysis of variance (ANOVA) followed by post-hoc 
comparisons using Scheffe test. Statistical significance was defined as p ≤ 0.05. 
Calculations were performed using SPSS version 18.0. 
 
RESULTS 
Expression of P-selectin 
 
Fig 1. Expression of P-selectin 
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P-selectin was continuously expressed at low levels upon adherence to different forms of 
chitosan (Fig. 1). The highest expression level of P-selectin was induced by O-C 53 
[20.71 (±8.50) ng/mL], followed by O-C [19.30 (±13.99) ng/mL]. Both O-C 53 and O-C 
increased 42.1% and 37.9%, respectively, compared to blood alone.  
 
Expression of TXA2 
 
Fig 2. Expression of TXA2 
The highest level of TXA2, [125.87 (±33.67) pg/mL] was released in the O-C group. O-C 
53 expressed nearly equivalent level, differing by 0.5% from O-C [125.26 (±35.27) 
pg/mL]. Expression mediated by O-C represented an increase of 12.17 ng/mL compared 
to the blood alone group [113.70 (±31.56) pg/mL]. No significant differences were noted 
between the tested groups (Fig. 2). 
 
Expression of TGF-β1 
 
Fig 3. Expression of TGF-β1 
The highest expression of TGF-β1 was seen with the Lyostypt control [55.62 (±37.0) 
pg/mL], followed by O-C [51.75 (±18.64) pg/mL] and 8% NO-CMC [42.28 (±26.72) 
pg/mL]. O-C and NO-CMC resulted in increases of 33.38% and 8.97%, respectively, 
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compared to blood alone. Lowered levels of TGF-β1 expression were observed with O-C 
53 with [36.45 (±14.29) pg/mL] and 7% NO-CMC [34.20 (±16.69) pg/mL] similar to 
blood alone (Fig. 3). 
 
Expression of PDGF-AB 
 
Fig 4. Expression of PDGF-AB 
O-C 53 resulted in the highest concentration of PDGF-AB released [1513.18 (±411.73) 
pg/mL]. O-C also reached approximately the same level [1503.71 (±460.02) pg/mL]. The 
other chitosans registered low levels of PDGF-AB compared to blood alone [1496.35 
(±392.34) pg/mL] (Fig. 4). 
Expression Comparison Mean difference (95% CI) p-value 
 
P-Selectin* 7% NO-CMC -1.73  (-10.92, 7.45) 0.995 
 8% NO-CMC 4.03  (-5.15, 13.21) 0.818 
 O-C -7.31  (-16.50, 1.87) 0.210 
 O-C 53 -8.72  (-17.91, 0.46) 0.074 
 Lyostypt -0.71 (-9.89, 8.48) 1.000 
TXA2** 7% NO-CMC -3.55  (-40.39, 33.29) 1.000 
 8% NO-CMC 1.85 (-34.99, 38.69) 1.000 
 O-C -12.17 (-49.00, 24.67) 0.939 
 O-C 53 -11.57 (-48.41, 25.27) 0.951 
 Lyostypt 2.73 (-34.11, 39.57) 1.000 
TGF-β1*** 7% NO-CMC 4.60 (-20.41, 29.62) 0.996 
 8% NO-CMC -3.48 (-28.50, 21.53) 0.999 
 O-C -12.95 (-37.97, 12.07) 0.689 
 O-C 53 2.35 (-22.67, 27.36) 1.000 
 Lyostypt -16.83 (-41.85, 8.19) 0.399 
PDGF-AB**** 7% NO-CMC 154.74 (-377.02, 686.49) 0.964 
 8% NO-CMC 152.02 (-379.74, 683.77) 0.967 
 O-C -7.36  (-539.11, 514.92) 1.000 
 O-C 53 -16.83 (-548.59, 514.92) 1.000 
 Lyostypt 178.97 (-353.78, 710.73) 0.934 
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Table 1. Comparison of means and p-values of tested chitosan –derivatives and blood 
alone  
F-stat (df) = [6.23 (5), p<0.005*], [ 0.74 (5), p=0.594**], [2.74 (5), p<0.022***], [0.71 
(5), p=0.615****] 
The significant F-tests for P-selectin and TGF-β1 indicate that the mean values of the 
tested biomaterials are different between these groups (Table 1). At the same time, no 
statistically significant differences were noted in TXA2 and PDGF-AB expression, even 
between groups. Post-hoc multiple comparisons using Scheffe test indicated that the p-
values between the mean differences of all the assayed chitosan –derivatives were not 
significant. However, as indicated by the negative values in the Table 1, differences in 
the means between the tested group and blood alone were noted for all of the factors 
evaluated. Our analyses successfully drew distinctions between tested groups (O-C, NO-
CMC) and blood alone. 
 
DISCUSSION 
Chitosan is recognized as a natural polymer; it is a non-toxic, biodegradable, 
biocompatible and bacteriostatic polysaccharide. Various chitosan matrices have been 
studied and manufactured for wound dressings with bioadhesive properties.
13,14
 A few 
studies reported that chitosan was able to induce intrinsic blood coagulation by inducing 
platelet adhesion, aggregation and activation
11, 15-17,20
. However, platelet aggregation is 
not the only correlate of successful blood coagulation.
11
 Michael and Perumal reported 
that P-selectin expression stabilized the initial platelet aggregation formed by 
glycoprotein IIb/IIIa-fibrinogen interactions, permitting the accumulation of large 
aggregations.
15
 P-selectin expression upon platelet activation has the potential to 
determine the size and stability of platelet aggregates, in addition to playing an important 
role in thrombosis.
18
 In our study, P-selectin was continuously expressed at a low level 
upon adherence to the various forms of chitosan, with differences in the means observed 
between the tested groups. Investigation of P-selectin expression in PRP might be 
affected by mechanical platelet activation during centrifugation.
9
 To minimize the 
possibility of mechanical platelet activation, three-way stopcocks were used to discard 
the first 1 mL of blood in the first syringe collected. Previously, it has been reported that 
the percentage of P-selectin induced by a chitosan-heparin composite scaffold was 
significantly reduced compared to that induced by a chitosan scaffold alone.
19
 At the 
same time, levels of P-selectin were higher on platelets exposed to chitosan compared to 
platelets isolated from whole blood. The expression of integrin α2β3 has been reported to 
be elevated in platelets that adhered to chitosan.
16
 This study produced results 
corroborating the findings of a great deal of our previous work in this field. We have 
reported that O-C affects thrombogenesis by changing the shape of platelets to 
pseudopodal, enabling aggregation.
20
  
Although no significant difference in TXA2 levels was noted between the tested groups, 
the O-C group showed an increased release of TXA2. It is documented that TXA2 has the 
ability to trigger a multitude of different signaling cascades that regulate cellular ion flux, 
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cytoskeletal arrangement, cell adhesion, motility, nuclear transcription factors, 
proliferation, cell survival and apoptosis.
21,22,23
 TXA2 plays a role in mediating the 
activation and recruitment of platelets to form the primary hemostatic plug. Apart from 
that, TXA2 is involved in stimulating platelet response to activate the hemostasis process 
and other immune responses.
24
 O-C has the ability to trigger TXA2 by activating new 
platelets at the site of injury and by increasing platelet aggregation.  
We investigated the release of TGF-β1 and PDGF-AB because both are important 
biochemical mediators in the wound healing process. Followed by Lyostypt, only O-C 
was able to elevate the expression of TGF-β1. O-C 53 showed decreased expression of 
TGF-β1. O-C and 8% NO-CMC are capable of causing the release of TGF-β1 from 
activated platelets and of stimulating the early stages of wound repair. These chitosans 
promote inflammatory responses and angiogenesis as well as the healing of acute and 
chronic wounds.
25-28
 Previously, TGF-β1 was released from chitosan microgranules, 
which had been discovered to have a drug-releasing capacity, into bone defects during a 
4-week testing period, and this treatment was found to accelerate bone regeneration and 
cell proliferation.
22
 Senel et al., investigated the potency of TGF-β1 in the presence of a 
chitosan gel, which was found to be able to assist and promote the healing of the oral 
mucosa.
26
 Our results are consistent with those of other studies, such as that of Okamoto 
et al., in which the authors concluded that chitosans induced the release of TGF-β1 and 
PDGF-AB from platelets.  
PDGF has the ability to initiate dermal regeneration, elevate local protein and collagen 
synthesis and promote endothelial migration or angiogenesis during wound healing.
29-30
 
Their study highlighted that cytokine secretion was dependent on the degree of 
membrane injury in platelets.
11
 This observation is consistent with our present study, 
where O-Cs were capable of inducing the expression of TGF-β1 and PDGF-AB. It is 
reported that solid-state chitosan has the ability to absorb platelets and accelerate 
hemostasis.
31
 These results support the use of chitosan derivatives as a potential 
hemostatic agent for surgical and injury-induced wound healing.
11
 The free NH2 group in 
solubilized chitosan reacts with functional groups on the cell surface and promotes 
chitosan migration across the wound area.
27
 From the previous finding, the extent of 
platelet activation in the presence of chitosan was found to be regulated by molecular 
weight, degree of deacetylation and addition of collagens. One of the reasons for the 
positive impact of O-C is its high degree of deacetylation (90%-95%). Chitosan films 
with a higher degree of deacetylation were found to be more brittle and harder to handle 
than those with a lower degree of deacetylation. The effect of degree of deacetylation on 
chitosan film biodegradation was also examined in rat tissues.
17
 It was also observed that 
cell adherence and development were not affected by the degree of deacetylation, 
contradicting a previous study where better cellular attachment was observed with a 
higher degree of deacetylation.
18
 However, our results suggest that degree of 
deacetylation, molecular weight and thickness of chitosan biomaterial play a crucial role 
in the absorption of platelets and in the expression of the factors studied. The purpose of 
this research paper was to study the expression of different blood-clotting mediators upon 
adherence to different chitosan derivatives. Our results raise many questions as to the 
mechanism of chitosan action following adhesion to blood cells. It is still not understood 
how and why chitosan biomaterials affect the release of the studied factors, other than the 
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potential influence imparted by chitosan properties such as degree of deacetylation, 
molecular weight, temperature, pH, viscosity and solubility. Although a considerable 
amount of literature has been published on chitosan as a hemostatic agent, the 
mechanisms of chitosan action are still under investigation. Future research should 
therefore concentrate on the investigation of physio- and bio-chemical alteration of 
chitosan biomaterials derived from chitin deacetylation. Further investigation on this 
topic needs to be undertaken before the effect of O-C and NO-CMC on hemostatic 
mechanisms is more clearly understood.  
 
CONCLUSIONS 
The most striking result that emerged from our present data was that O-C was superior to 
NO-CMC in activating platelets to form the primary hemostatic plug prior to coagulation. 
In our present assessment, an attempt has been made to understand the expression of P-
selectin, TXA2, TGF-β1 and PDGF-AB in the presence of chitosan derivatives in various 
formulations. Because we used two different forms of O-C, we concluded that properties 
such as concentration, degree of deacetylation, roughness and thickness of chitosan 
derivatives are determinants of the enhanced hemostatic activity observed. Taken 
together, the current results are supported by our previous research reporting 
enhancement of platelet adhesion and aggregation by O-Cs. The relevance of these 
enhancements in platelet function was underscored by our current findings. 
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